Tender

Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F02: Contract notice

Notice identifier: 2025/S 000-003445

Procurement identifier (OCID): ocds-h6vhtk-04c7d0

Published 3 February 2025, 11:39am



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

10 South Colonnade

London

E14 4PU

Contact

Chantal Jockel

Email

vmc.vaccines@ukhsa.gov.uk

Country

United Kingdom

Region code

UKI42 - Tower Hamlets

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://health-family.force.com/s/Welcome

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://health-family.force.com/s/Welcome

Tenders or requests to participate must be submitted to the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

Reference number

CM/PHV/25/C296805

two.1.2) Main CPV code

  • 33651600 - Vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

Provision of measles, mumps, rubella and varicella (MMRV) vaccine (2025)

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

To a location in the United Kingdom to be notified to the successful bidder(s) following contract award.

two.2.4) Description of the procurement

The provision of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 11.5 million doses. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The awarding of lots is not appropriate for this procurement.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start date

1 October 2025

End date

30 September 2029

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

This contract has the option to be extended for a period or periods up to an additional 24 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2024/S 000-040220

four.2.2) Time limit for receipt of tenders or requests to participate

Date

10 March 2025

Local time

1:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

10 March 2025

Local time

1:00pm

Place

Atamis

Information about authorised persons and opening procedure

Opened by a UK Health Security Agency employee


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional information

Responding to this notice: suppliers who do not respond to this procurement exercise in the following manner may be disqualified from the procurement process provided that the following conditions will operate in addition to and not replace any other conditions stated in the procurement documents which may result in disqualification.
1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at https://health-family.force.com/s/Welcome Candidates wishing to be considered for this procurement exercise must register and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) if not already registered, candidates should register on the eTendering portal at https://health-family.force.com/s/Welcome and click the link to register:
— ‘accept the terms and conditions’,
— enter your correct business details,
— click ‘Submit’ when complete,
— you will shortly receive an email from the Salesforce platform asking you to finalise your registration;
1.2) once registered, candidates must express interest as follows:
(a) login to the eTendering portal,
(b) select ‘View our Live Opportunities’,
(c) select the opportunity that you are interested in,
(d) ‘Register interest’,
(e) select ‘confirm’,
(f) once you have expressed interest, it will move to ‘My Proposals and Quotes’, where you can download additional documentation (if required) and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button;
1.3) for any support in registering on the portal or submitting your expression of interest please contact the Atamis Help-desk at +44 8009956035 or support-health@atamis.co.uk
2) General supplier information. To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, supplier registration, as follows
2.1) If not already registered, candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top right of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S Number to enable registration on supplier registration.
2.2) Once registration is complete you are able to create and update your registered company profile. Candidates should ensure all the mandatory fields of their supplier registration profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.
2.3) For further help or information concerning supplier registration, please contact the Helpdesk at:support@nqc.com or telephone +44(0)1614137982.
Other contracting authorities
The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.

six.4) Procedures for review

six.4.1) Review body

High Court

The Strand

London

WC2A 2LL

Country

United Kingdom